Majority Reverses Dismissal Of Class Action Complaint Over Prescription Eye Medication

Mealey's (November 6, 2017, 10:45 AM EST) -- PHILADELPHIA — A majority of the Third Circuit U.S. Court of Appeals on Oct. 18 reversed and remanded a lower court’s dismissal of a class action consumer protection lawsuit against manufacturers and distributors of prescription eye drop medications that are approved by the Food and Drug Administration to treat serious glaucoma and other serious medical conditions (Leonard Cottrell, et al. v. Alcon Laboratories, et al., No. 16-2015, 3rd Cir., 2017 U.S. App. LEXIS 20341)....

Attached Documents

Related Sections